[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100350139":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":19,"locations":24,"responsibleParty":127,"collaborators":11,"id":129,"slug":130,"hasResults":131,"nctId":132,"briefTitle":133,"officialTitle":133,"acronym":11,"eligibilityCriteria":134,"healthyVolunteers":131,"sex":135,"minAge":136,"maxAge":11,"enrollmentInfo":137,"targetDuration":11,"studyType":140,"phases":141,"briefSummary":143,"conditions":144,"keywords":146,"overallStatus":68,"whyStopped":11,"lastUpdateSubmitDate":151,"lastUpdatePostDateStruct":152,"startDateStruct":155,"completionDateStruct":157,"leadSponsor":159,"locationsCount":160},{"fullName":5,"class":6},"Vanda Pharmaceuticals","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Trichostatin A","EXPERIMENTAL",null,[13],"Drug: Trichostatin A",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":11},"DRUG","Intravenous Infusion",[9],[20],{"name":5,"role":21,"phone":22,"phoneExt":11,"email":23},"CONTACT","202-734-3400","clinicaltrials@vandapharma.com",[25,39,49,58,67,79,88,95,104,111,120],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":11},"Vanda Investigational Site","WITHDRAWN","Washington D.C.","District of Columbia","20007","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-77.03637,38.89511,{"lat":37,"lon":36},{"facility":26,"status":40,"city":41,"state":42,"zip":43,"country":31,"countryCode":32,"cosmosGeoPoint":44,"geoPoint":48,"contacts":11},"COMPLETED","Lafayette","Indiana","47905",{"type":34,"coordinates":45},[46,47],-86.87529,40.4167,{"lat":47,"lon":46},{"facility":26,"status":27,"city":50,"state":51,"zip":52,"country":31,"countryCode":32,"cosmosGeoPoint":53,"geoPoint":57,"contacts":11},"Hackensack","New Jersey","07601",{"type":34,"coordinates":54},[55,56],-74.04347,40.88593,{"lat":56,"lon":55},{"facility":26,"status":40,"city":59,"state":60,"zip":61,"country":31,"countryCode":32,"cosmosGeoPoint":62,"geoPoint":66,"contacts":11},"Seattle","Washington","98109",{"type":34,"coordinates":63},[64,65],-122.33207,47.60621,{"lat":65,"lon":64},{"facility":26,"status":68,"city":69,"state":11,"zip":11,"country":70,"countryCode":71,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"RECRUITING","Biała Podlaska","Poland","PL",{"type":34,"coordinates":73},[74,75],23.11652,52.03238,{"lat":75,"lon":74},[78],{"name":5,"role":21,"phone":22,"phoneExt":11,"email":11},{"facility":26,"status":68,"city":80,"state":11,"zip":11,"country":70,"countryCode":71,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Katowice",{"type":34,"coordinates":82},[83,84],19.02173,50.2597,{"lat":84,"lon":83},[87],{"name":5,"role":21,"phone":22,"phoneExt":11,"email":11},{"facility":26,"status":40,"city":89,"state":11,"zip":11,"country":70,"countryCode":71,"cosmosGeoPoint":90,"geoPoint":94,"contacts":11},"Krakow",{"type":34,"coordinates":91},[92,93],19.93658,50.06143,{"lat":93,"lon":92},{"facility":26,"status":68,"city":96,"state":11,"zip":11,"country":70,"countryCode":71,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"Opole",{"type":34,"coordinates":98},[99,100],17.92604,50.67119,{"lat":100,"lon":99},[103],{"name":5,"role":21,"phone":22,"phoneExt":11,"email":11},{"facility":26,"status":40,"city":105,"state":11,"zip":11,"country":70,"countryCode":71,"cosmosGeoPoint":106,"geoPoint":110,"contacts":11},"Skorzewo",{"type":34,"coordinates":107},[108,109],17.97006,54.16909,{"lat":109,"lon":108},{"facility":26,"status":68,"city":112,"state":11,"zip":11,"country":70,"countryCode":71,"cosmosGeoPoint":113,"geoPoint":117,"contacts":118},"Warsaw",{"type":34,"coordinates":114},[115,116],21.01178,52.22977,{"lat":116,"lon":115},[119],{"name":5,"role":21,"phone":22,"phoneExt":11,"email":11},{"facility":26,"status":40,"city":121,"state":11,"zip":11,"country":70,"countryCode":71,"cosmosGeoPoint":122,"geoPoint":126,"contacts":11},"Wroclaw",{"type":34,"coordinates":123},[124,125],17.03006,51.10286,{"lat":125,"lon":124},{"type":128,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100350139","phase-1-tolerability-study-of-trichostatin-a-in-subjects-with-relapsed-or-refractory-hematologic-malignancies-100350139",false,"NCT03838926","Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies","Inclusion Criteria:\n\n* Subject is ≥ 18 years at the time of signing informed consent;\n* Confirmed malignant hematologic disease or lymphoid malignancy that has relapsed or is refractory to standard therapy and has exhausted all available therapies;\n* Presence of measurable or evaluable disease;\n* Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 2;\n* Contraceptives or other approved avoidance of pregnancy measures\n\nExclusion Criteria:\n\n* Allogeneic stem cell transplant recipient presenting with graft versus host disease (GVHD) either active or requiring immunosuppression;\n* Concomitantly taking anti-cancer therapy (bisphosphonates are permitted);\n* Undergone major surgery ≤ 2 weeks prior to starting study drug;\n* Evidence of mucosal or internal bleeding;\n* Impaired cardiac function or conduction defect;\n* Concurrent severe and\u002For uncontrolled medical conditions","ALL","18 Years",{"count":138,"type":139},42,"ESTIMATED","INTERVENTIONAL",[142],"PHASE1","The aim of this study is to investigate the safety and tolerability of trichostatin A in individuals with relapsed or refractory hematologic malignancies.",[145],"Relapsed or Refractory Hematologic Malignancies",[147,148,149,150],"Hematologic","Malignancies","Cancer","Blood","2026-03-12",{"date":153,"type":154},"2026-03-16","ACTUAL",{"date":156,"type":154},"2018-09-27",{"date":158,"type":139},"2027-12",{"name":5,"class":6},11]